IA
RMD icon

IndexIQ Advisors’s ResMed RMD Stock Holding History

IndexIQ Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$586K Sell
2,416
-5
-0.2% -$1.21K 0.02% 371
2021
Q4 		$631K Sell
2,421
-84
-3% -$21.8K 0.02% 425
2021
Q3 		$660K Buy
2,505
+123
+5% +$33.6K 0.02% 398
2021
Q2 		$587K Buy
2,382
+80
+3% +$16.8K 0.02% 397
2021
Q1 		$447K Buy
2,302
+288
+14% +$57.8K 0.02% 406
2020
Q4 		$428K Buy
2,014
+943
+88% +$188K 0.02% 458
2020
Q3 		$184K Buy
1,071
+645
+151% +$119K 0.01% 711
2020
Q2 		$82K Buy
426
+377
+769% +$61.7K ﹤0.01% 857
2020
Q1 		$7K Sell
49
-1
-2% -$159 ﹤0.01% 863
2019
Q4 		$8K Buy
+50
New +$7.21K ﹤0.01% 673

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

IndexIQ Advisors's RMD Position: Q1 2022 in Review

IndexIQ Advisors reduced its ResMed (RMD) stake by 0.21% in Q1 2022, selling an estimated $1.21K and leaving 2,416 shares worth $586K. The position accounts for 0.02% of the portfolio, ranked #371.

IndexIQ Advisors first reported a position in RMD in Q4 2019 and has held it in 10 quarters since. The position peaked at $660K in Q3 2021. 682 funds tracked by Wall St. Rank hold RMD as of Q1 2022.

  • IndexIQ Advisors held 2,416 shares of ResMed worth $586K as of Q1 2022.
  • IndexIQ Advisors sold 5 ResMed shares in Q1 2022, an estimated $1.21K.
  • ResMed made up 0.02% of IndexIQ Advisors's portfolio in Q1 2022, its #371 holding.
  • IndexIQ Advisors first reported a position in ResMed in Q4 2019 and has held it in 10 quarters since.
  • IndexIQ Advisors's ResMed position peaked at $660K in Q3 2021.
  • 682 funds tracked by Wall St. Rank held ResMed as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.